RE:RE:xB3-001 Potential Revenue Estimations beenthere asked/stated, "Why is there such a big disconnect between this and BTI's trying to raise funds? I would think investors would be lining up!"
and...
"Why doesn't some pharma just buy BTI out? Looks like quite a bargain to me considering the potential."
Hindsight is 20/20, beenthere, but it appears that Bioasis has not proven xB3 sufficiently to make significant (full-value) deals. The company thought it could do licencing deals with only a few animal studies but without NHP studies or early clinical trials. I think the company had good reason to think deals could get done but they didn't happen. And so, years late, we are finally on what I think is the correct path. Bioasis did not begin the real development of its commercial opportunities until the last year or so. That's my opinion of it.
Programs and their projected timelines mean little to many shareholders. I get it. The wait has been awful and people don't want to wait any longer. As a result, public commentary by Bioasis shareholders has been overwhelmingly negative. In my opinion, it illustrates astonishingly bad judgement and tactics to publicly denigrate the company, its officers and directors (and the hired help). As a shareholder, how could you ridicule Kootenay123 by telling him, essentially, that he's crazy to think that the share price could go from 25¢ to $25?
It's crazy bad judgement for a shareholder to state that he sees little or no hope of the share price going up. YOU OWN THE VERY SHARES YOU CONTEND ARE ESSENTIALLY WORTHLESS, OR AT BEST, THEY'RE A LOUSY INVESTMENT. You and The Others give off the public impression that Bioasis shareholders are negative and that they have little hope for success, even though the only programs that can create success are barely underway.
But you're free to do it. It's your right. But, honestly, as sales people for your own cause, you stink. You've been doing the same thing for years. ZERO SHAREHOLDER ENTHUSIASM = LOW SHARE PRICE. Why would a new investor be enthused when the current shareholders publicly appear so negative? I wouldn't hire you guys to collect parking fees in a closed booth, a job where you don't have to open your mouths for years at a time. But you're going to keep on doing the damage until Bioasis generates news that not even you guys can negate.
As for why some pharma hasn't bought us out, the reason is simple. xB3-001 is worth hundreds of millions in a milestones deal, right now, possibly a billion after phase one. Then there's the value of the other pipeline programs, other programs yet to come, licencing deal potential, and the value of the xB3 IP. That's a lot of value! There are those who say they'll take $2, $3, for it. I say to them, go ahead, sell on the way through $2 and $3 while the rest of us are on the way to $5, $18, $40, or $57.23, whatever.
The pharmas won't buy us because they can't. We won't sell it to them. Yet.
jdstox
ps. For the record, I have no hope that you and the other nattering nabobs of negativism will change your ways and get behind the company. You should harbour no hope that I'll go away, either. In your face, all the way to the end, whatever that end turns out to be.
.
.